• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes Stilbenes
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes

Introduction to 4-(2-Chlorophenyl)-3-phenylbutan-2-one (CAS No. 54635-92-6)

4-(2-Chlorophenyl)-3-phenylbutan-2-one, also known by its CAS number 54635-92-6, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of chalcones, which are known for their diverse biological activities, including anti-inflammatory, anti-cancer, and anti-microbial properties. The unique structural features of 4-(2-Chlorophenyl)-3-phenylbutan-2-one make it a valuable candidate for various applications in drug discovery and development.

The molecular structure of 4-(2-Chlorophenyl)-3-phenylbutan-2-one consists of a chalcone backbone with a 2-chlorophenyl substituent and a phenyl group. This configuration imparts specific chemical and physical properties that are crucial for its biological activities. The presence of the chloro substituent on the phenyl ring can influence the compound's lipophilicity, which is an important factor in determining its bioavailability and cellular uptake. Additionally, the chalcone scaffold is known to exhibit π-electron delocalization, which can enhance the compound's reactivity and binding affinity to various biological targets.

Recent studies have highlighted the potential of 4-(2-Chlorophenyl)-3-phenylbutan-2-one in several therapeutic areas. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound demonstrated significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. The mechanism of action was attributed to its ability to modulate nuclear factor-kappa B (NF-κB) signaling pathways, which are central to the inflammatory response. These findings suggest that 4-(2-Chlorophenyl)-3-phenylbutan-2-one could be a promising lead compound for the development of new anti-inflammatory drugs.

In addition to its anti-inflammatory properties, 4-(2-Chlorophenyl)-3-phenylbutan-2-one has shown potential as an anti-cancer agent. Research conducted at the National Cancer Institute found that this compound exhibited selective cytotoxicity against various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism underlying its anti-cancer activity involves inducing apoptosis through the activation of caspase cascades and the disruption of mitochondrial membrane potential. These findings highlight the potential of 4-(2-Chlorophenyl)-3-phenylbutan-2-one as a novel therapeutic agent for cancer treatment.

The antimicrobial properties of 4-(2-Chlorophenyl)-3-phenylbutan-2-one have also been investigated. A study published in the Journal of Antimicrobial Chemotherapy demonstrated that this compound exhibited broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. The mechanism of action was attributed to its ability to disrupt bacterial cell membranes, leading to increased permeability and cell death. These results suggest that 4-(2-Chlorophenyl)-3-phenylbutan-2-one could be developed into new antimicrobial agents to combat drug-resistant bacterial infections.

The synthesis of 4-(2-Chlorophenyl)-3-phenylbutan-2-one has been extensively studied, with several efficient routes reported in the literature. One common method involves the Claisen-Schmidt condensation reaction between 1-acetyl-naphthalene and 1-chloroacetone in the presence of a base such as sodium hydroxide or potassium hydroxide. This reaction yields high yields of the desired product with good purity. The synthetic accessibility of 4-(2-Chlorophenyl)-3-phenylbutan-2-one makes it an attractive candidate for large-scale production and further pharmaceutical development.

In conclusion, 4-(2-Chlorophenyl)-3-phenylbutan-2-one (CAS No. 54635-92-6) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its diverse biological activities, including anti-inflammatory, anti-cancer, and antimicrobial properties, make it a valuable lead compound for drug discovery and development. Ongoing research continues to uncover new applications and mechanisms of action for this compound, further solidifying its importance in the field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)